Market closed
Repro Med Systems/$KRMD
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Repro Med Systems
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Ticker
$KRMD
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
-
Website
KRMD Metrics
BasicAdvanced
$184M
Market cap
-
P/E ratio
-$0.26
EPS
0.41
Beta
-
Dividend rate
Price and volume
Market cap
$184M
Beta
0.41
52-week high
$4.24
52-week low
$1.98
Average daily volume
80K
Financial strength
Current ratio
2.993
Quick ratio
2.221
Long term debt to equity
18.792
Total debt to equity
23.936
Management effectiveness
Return on assets (TTM)
-14.05%
Return on equity (TTM)
-53.01%
Valuation
Price to revenue (TTM)
5.728
Price to book
10.35
Price to tangible book (TTM)
10.81
Price to free cash flow (TTM)
-104.449
Growth
Revenue change (TTM)
11.57%
Earnings per share change (TTM)
44.34%
3-year revenue growth (CAGR)
14.96%
3-year earnings per share growth (CAGR)
38.06%
What the Analysts think about KRMD
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Repro Med Systems stock.
KRMD Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
KRMD Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
KRMD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Repro Med Systems stock?
Repro Med Systems (KRMD) has a market cap of $184M as of December 26, 2024.
What is the P/E ratio for Repro Med Systems stock?
The price to earnings (P/E) ratio for Repro Med Systems (KRMD) stock is 0 as of December 26, 2024.
Does Repro Med Systems stock pay dividends?
No, Repro Med Systems (KRMD) stock does not pay dividends to its shareholders as of December 26, 2024.
When is the next Repro Med Systems dividend payment date?
Repro Med Systems (KRMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Repro Med Systems?
Repro Med Systems (KRMD) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.